International Journal on Science and Technology

E-ISSN: 2229-7677   •   Impact Factor: 9.88

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 17 Issue 2 April-June 2026 Submit your research before last 3 days of June to publish your research paper in the issue of April-June.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 17 Issue 2
April-June 2026

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Neurodevelopmental Integrity and Substance Risk: A Developmental Public Health Model for Education, Risk Literacy, and Adult Autonomy

Author(s) Dr. Elias Rubenstein
Country United States
Abstract Modern substance discourse is often organized around legal, medical, and cultural labels: legal drugs, illegal drugs, prescription medicines, over-the-counter products, recreational substances, controlled substances, and commercially normalized stimulants. These labels are administratively useful, but they are not reliable indicators of neurodevelopmental safety. A developing brain responds to pharmacology, timing, dose, frequency, potency, route of administration, psychological vulnerability, setting, medical necessity, commercial context, and pharmacological interaction.
This paper advances neurodevelopmental integrity as a guiding concept for substance education, developmental risk literacy, and adult harm reduction. Neurodevelopmental integrity refers to the developing neural, psychological, behavioral, and bodily capacities that support attention, learning, memory, emotional regulation, impulse control, reward evaluation, bodily awareness, sleep regulation, and future autonomy. The concept is derived from three observations: important aspects of brain maturation continue into young adulthood; many substances affect systems involved in reward, inhibition, memory, mood, stress, sleep, pain, and perception; and inherited legal, medical, commercial, or cultural categories often fail to reflect developmental risk.
The paper uses selected substance categories as illustrative cases: alcohol, nicotine, highly caffeinated beverages and energy drinks, cannabis, opioids, benzodiazepines, stimulant medication, antidepressants, over-the-counter analgesics, party drugs, classic psychedelics, and interaction-related risks. These substances are not treated as equivalent. The model evaluates multidimensional exposure conditions rather than relying on binary moral, legal, or administrative classifications of substances. It asks how age, setting, dose, frequency, mental state, medical history, medication use, polydrug exposure, commercial normalization, sleep disruption, and interaction literacy shape risk.
The paper argues for a substance culture centered on education, proportionality, developmental honesty, behavioral skill-building, and accurate risk communication. For adolescents and emerging adults, substance education should emphasize neurodevelopmental awareness, risk literacy, interaction literacy, caffeine and sleep literacy, coping capacity, social decision-making, and informed delay of avoidable exposure. For mature adults, policy should give greater weight to informed autonomy, harm reduction, comparative risk assessment, and safe contexts. A mature substance culture does not normalize familiar risks or demonize unfamiliar ones. It teaches how pharmacological effects change across age, context, vulnerability, purpose, setting, commercial environment, and interaction.
Keywords neurodevelopmental integrity, adolescent brain development, substance education, developmental risk literacy, adult autonomy, harm reduction, alcohol, nicotine, caffeine, energy drinks, cannabis, psychedelics, opioids, benzodiazepines, attention-deficit/hyperactivity disorder medication, antidepressants, painkillers, drug interactions
Field Sociology > Health
Published In Volume 17, Issue 2, April-June 2026
Published On 2026-06-20
View / Download PDF File

Share this


CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJSAT DOI prefix is
10.71097/IJSAT

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 17 Isu 2Cover Page Vol 17 Isu 1Cover Page Vol 16 Isu 4

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJSAT
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us Message on WhatsApp +91-9687-182-185 editor@ijsat.org